Cargando…
P1453: STABLE TRANSDUCTION OF FETAL HEMOGLOBIN IN PATIENTS WITH SICKLE CELL DISEASE IN THE PHASE 1/2 MOMENTUM STUDY OF ARU-1801 GENE THERAPY AND REDUCED INTENSITY CONDITIONING
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429142/ http://dx.doi.org/10.1097/01.HS9.0000848668.22824.43 |
_version_ | 1784779344031252480 |
---|---|
author | Grimley, M. Kent, M. Asnani, M. Shrestha, A. Felker, S. Lutzko, C. Arumugam, P. Witting, S. Knight-Madden, J. Niss, O. Quinn, C. Lo, C. Little, C. Dong, A. Malik, P. |
author_facet | Grimley, M. Kent, M. Asnani, M. Shrestha, A. Felker, S. Lutzko, C. Arumugam, P. Witting, S. Knight-Madden, J. Niss, O. Quinn, C. Lo, C. Little, C. Dong, A. Malik, P. |
author_sort | Grimley, M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9429142 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94291422022-08-31 P1453: STABLE TRANSDUCTION OF FETAL HEMOGLOBIN IN PATIENTS WITH SICKLE CELL DISEASE IN THE PHASE 1/2 MOMENTUM STUDY OF ARU-1801 GENE THERAPY AND REDUCED INTENSITY CONDITIONING Grimley, M. Kent, M. Asnani, M. Shrestha, A. Felker, S. Lutzko, C. Arumugam, P. Witting, S. Knight-Madden, J. Niss, O. Quinn, C. Lo, C. Little, C. Dong, A. Malik, P. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429142/ http://dx.doi.org/10.1097/01.HS9.0000848668.22824.43 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Grimley, M. Kent, M. Asnani, M. Shrestha, A. Felker, S. Lutzko, C. Arumugam, P. Witting, S. Knight-Madden, J. Niss, O. Quinn, C. Lo, C. Little, C. Dong, A. Malik, P. P1453: STABLE TRANSDUCTION OF FETAL HEMOGLOBIN IN PATIENTS WITH SICKLE CELL DISEASE IN THE PHASE 1/2 MOMENTUM STUDY OF ARU-1801 GENE THERAPY AND REDUCED INTENSITY CONDITIONING |
title | P1453: STABLE TRANSDUCTION OF FETAL HEMOGLOBIN IN PATIENTS WITH SICKLE CELL DISEASE IN THE PHASE 1/2 MOMENTUM STUDY OF ARU-1801 GENE THERAPY AND REDUCED INTENSITY CONDITIONING |
title_full | P1453: STABLE TRANSDUCTION OF FETAL HEMOGLOBIN IN PATIENTS WITH SICKLE CELL DISEASE IN THE PHASE 1/2 MOMENTUM STUDY OF ARU-1801 GENE THERAPY AND REDUCED INTENSITY CONDITIONING |
title_fullStr | P1453: STABLE TRANSDUCTION OF FETAL HEMOGLOBIN IN PATIENTS WITH SICKLE CELL DISEASE IN THE PHASE 1/2 MOMENTUM STUDY OF ARU-1801 GENE THERAPY AND REDUCED INTENSITY CONDITIONING |
title_full_unstemmed | P1453: STABLE TRANSDUCTION OF FETAL HEMOGLOBIN IN PATIENTS WITH SICKLE CELL DISEASE IN THE PHASE 1/2 MOMENTUM STUDY OF ARU-1801 GENE THERAPY AND REDUCED INTENSITY CONDITIONING |
title_short | P1453: STABLE TRANSDUCTION OF FETAL HEMOGLOBIN IN PATIENTS WITH SICKLE CELL DISEASE IN THE PHASE 1/2 MOMENTUM STUDY OF ARU-1801 GENE THERAPY AND REDUCED INTENSITY CONDITIONING |
title_sort | p1453: stable transduction of fetal hemoglobin in patients with sickle cell disease in the phase 1/2 momentum study of aru-1801 gene therapy and reduced intensity conditioning |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429142/ http://dx.doi.org/10.1097/01.HS9.0000848668.22824.43 |
work_keys_str_mv | AT grimleym p1453stabletransductionoffetalhemoglobininpatientswithsicklecelldiseaseinthephase12momentumstudyofaru1801genetherapyandreducedintensityconditioning AT kentm p1453stabletransductionoffetalhemoglobininpatientswithsicklecelldiseaseinthephase12momentumstudyofaru1801genetherapyandreducedintensityconditioning AT asnanim p1453stabletransductionoffetalhemoglobininpatientswithsicklecelldiseaseinthephase12momentumstudyofaru1801genetherapyandreducedintensityconditioning AT shresthaa p1453stabletransductionoffetalhemoglobininpatientswithsicklecelldiseaseinthephase12momentumstudyofaru1801genetherapyandreducedintensityconditioning AT felkers p1453stabletransductionoffetalhemoglobininpatientswithsicklecelldiseaseinthephase12momentumstudyofaru1801genetherapyandreducedintensityconditioning AT lutzkoc p1453stabletransductionoffetalhemoglobininpatientswithsicklecelldiseaseinthephase12momentumstudyofaru1801genetherapyandreducedintensityconditioning AT arumugamp p1453stabletransductionoffetalhemoglobininpatientswithsicklecelldiseaseinthephase12momentumstudyofaru1801genetherapyandreducedintensityconditioning AT wittings p1453stabletransductionoffetalhemoglobininpatientswithsicklecelldiseaseinthephase12momentumstudyofaru1801genetherapyandreducedintensityconditioning AT knightmaddenj p1453stabletransductionoffetalhemoglobininpatientswithsicklecelldiseaseinthephase12momentumstudyofaru1801genetherapyandreducedintensityconditioning AT nisso p1453stabletransductionoffetalhemoglobininpatientswithsicklecelldiseaseinthephase12momentumstudyofaru1801genetherapyandreducedintensityconditioning AT quinnc p1453stabletransductionoffetalhemoglobininpatientswithsicklecelldiseaseinthephase12momentumstudyofaru1801genetherapyandreducedintensityconditioning AT loc p1453stabletransductionoffetalhemoglobininpatientswithsicklecelldiseaseinthephase12momentumstudyofaru1801genetherapyandreducedintensityconditioning AT littlec p1453stabletransductionoffetalhemoglobininpatientswithsicklecelldiseaseinthephase12momentumstudyofaru1801genetherapyandreducedintensityconditioning AT donga p1453stabletransductionoffetalhemoglobininpatientswithsicklecelldiseaseinthephase12momentumstudyofaru1801genetherapyandreducedintensityconditioning AT malikp p1453stabletransductionoffetalhemoglobininpatientswithsicklecelldiseaseinthephase12momentumstudyofaru1801genetherapyandreducedintensityconditioning |